2019
Carcinomas in the children and young adults: A report form Children’s Oncology Group APEC14B1 study.
Venkatramani R, Piao J, Krailo M, Rodriguez-Galindo C, Pashankar F. Carcinomas in the children and young adults: A report form Children’s Oncology Group APEC14B1 study. Journal Of Clinical Oncology 2019, 37: e21505-e21505. DOI: 10.1200/jco.2019.37.15_suppl.e21505.Peer-Reviewed Original ResearchYoung adultsDistant metastasisThyroid cancerChildren's Oncology Group institutionsPercent of patientsEnrollment of patientsRenal cell carcinomaBiology of carcinomaFemale predominanceLymph nodesMedian ageCell carcinomaColorectal cancerCancer patientsMetastasis statusAdrenocortical cancerEpidemiologic informationNasopharyngeal carcinomaWhite raceOutcome studiesPatientsCarcinomaTissue submissionEligibility screeningAge groups
2016
Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): Results of the Children’s Oncology Group ARAR0331 study.
Rodriguez-Galindo C, Krailo M, Krasin M, McCarville M, Hicks J, Pashankar F, Pappo A. Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): Results of the Children’s Oncology Group ARAR0331 study. Journal Of Clinical Oncology 2016, 34: 10513-10513. DOI: 10.1200/jco.2016.34.15_suppl.10513.Peer-Reviewed Original ResearchTreatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children’s Oncology Group ARAR0332 protocol.
Rodriguez-Galindo C, Pappo A, Krailo M, Pashankar F, Monteiro Caran E, Hicks J, McCarville M, Weldon C, Malkin D, Zambetti G, Filho A, LaQuaglia M, Mastellaro M, Ribeiro R. Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children’s Oncology Group ARAR0332 protocol. Journal Of Clinical Oncology 2016, 34: 10515-10515. DOI: 10.1200/jco.2016.34.15_suppl.10515.Peer-Reviewed Original Research
2012
Children's Oncology Group's 2013 blueprint for research: Rare tumors
Rodriguez‐Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G, Committee O. Children's Oncology Group's 2013 blueprint for research: Rare tumors. Pediatric Blood & Cancer 2012, 60: 1016-1021. PMID: 23255219, PMCID: PMC4304764, DOI: 10.1002/pbc.24428.Peer-Reviewed Original ResearchConceptsGerm cell tumorsCell tumorsRare cancersChildren's Oncology Group's 2013 blueprintInternational phase 3 clinical trialsPhase 3 clinical trialsEvidence-based definitionIntraocular retinoblastomaAdvanced carcinomaRisk stratificationInfrequent malignancyRare tumorClinical trialsClinical studiesLiver tumorsTumorsBiologic studiesChildrenCancerRetinoblastomaCarcinomaMalignancyHepatoblastomaYearsTrialsManagement of Thyroid Carcinoma in Children and Young Adults
Rapkin L, Pashankar FD. Management of Thyroid Carcinoma in Children and Young Adults. Journal Of Pediatric Hematology/Oncology 2012, 34: s39-s46. PMID: 22525405, DOI: 10.1097/mph.0b013e31824e37a6.Peer-Reviewed Original ResearchConceptsMedullary thyroid cancerThyroid cancerRadioactive iodineCancers of childhoodSuppression of thyroidPediatric carcinomasAdjuvant benefitNew medicationsSuspicious lesionsThyroid carcinomaBeneficial treatmentCancerAdolescent treatmentPatientsYoung adultsAdult dataWDTCSurgeryCarcinomaTreatmentChildhoodLow thresholdLarge groupMedicationsVandetanib